Skip to main content
. 2018 Jun 11;8:8823. doi: 10.1038/s41598-018-27307-2

Figure 1.

Figure 1

Kaplan-Meier estimates of the OS and DFS in GEO and TCGA patients using the seven-lncRNA signature. The Kaplan-Meier curves were used to visualize and compare the OS of the low-risk versus high-risk group in GEO training set (A), GEO validation set (B) and TCGA test set (C). The Kaplan-Meier curves for the DFS of low-risk versus high-risk group in TCGA test set was also plotted (D).